ACORN's unique data warehouse enables pharmacoeconomic and health outcomes analysis previously unachievable. "In addition to traditional sources of information, we have a unique component in our PACE PRO gathering capability which allows us to scientifically analyze patients' symptom burden and quality of life," states Mark Walker, PhD, Director of Scientific Management. "Historically, the analysis of treatments and outcomes, either clinical or economic across different patient populations, has not included rigorous measurements of patient-reported outcomes, both physical and psychological. In addition, Pharma and payer sectors are finding increased value from ACORN's immediate access to hundreds of thousands of oncology patients."
Analytical results are routinely published in peer-reviewed journals and presented at major scientific meetings. For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.
Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN
focuses on oncology exclusively. ACORN offers centralized clinical trial
services, scientific analysis, and is a full-service Clinical Research
Organization (CRO), providing contract and budgeting services; fostering
accrual of subjects at the site level; collecting data and monitoring its
accuracy; and working seamlessly with both trial sponsors and participating
|SOURCE Accelerated Community Oncology Research Network|
Copyright©2008 PR Newswire.
All rights reserved